Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/FCF ratio high or low?
The EV/FCF ratio of 124.88x is 627% above its estimated 5-year average of 17.18x, near the high end of its estimated 5-year range (9.78x–144.11x).
As of 2026-10-06T20:43:14.479Z. 226.84% above its estimated 12-month average of 38.21x.
Calculation as of: 2026-10-06T20:43:14.479Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3747b4faccdf63e20ad288f6e4ea1c731bb156956f174f9644dca84b64e32f29
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
124.88x
EV/FCF RATIO AVG TTM
38.21x
EV/FCF RATIO AVG 3Y
19.60x
EV/FCF RATIO AVG 5Y
17.18x
EV/FCF RATIO AVG 10Y
17.20x
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+226.84%
CURRENT VS 3Y AVG
+537.22%
CURRENT VS 5Y AVG
+626.95%
CURRENT VS 10Y AVG
+625.99%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
24.80x
median of 204 covered companies
CURRENT VS SECTOR MEDIAN
+403.55%
vs the sector median at left
Supernus Pharmaceuticals, Inc.
Market Cap
$2.49B
EV/FCF Ratio
124.88x
TTM Avg
38.21x
3Y Avg
19.60x
5Y Avg
17.18x
Market Cap
$2.43B
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.56B
EV/FCF Ratio
N/A
TTM Avg
22.38x
3Y Avg
30.75x
5Y Avg
68.64x
Market Cap
$2.38B
EV/FCF Ratio
29.45x
TTM Avg
35.75x
3Y Avg
35.25x
5Y Avg
31.41x
Market Cap
$2.60B
EV/FCF Ratio
N/A
TTM Avg
44.45x
3Y Avg
44.45x
5Y Avg
44.45x
Market Cap
$2.60B
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.36B
EV/FCF Ratio
20.84x
TTM Avg
65.64x
3Y Avg
95.37x
5Y Avg
95.37x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Supernus Pharmaceuticals, Inc. (SUPN) | $2.49B | 124.88x | 38.21x | 19.60x | 17.18x |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.43B | N/A | N/A | N/A | N/A |
| Privia Health Group, Inc. (PRVA)vs › | $2.56B | N/A | 22.38x | 30.75x | 68.64x |
| Clover Health Investments, Corp. (CLOV)vs › | $2.38B | 29.45x | 35.75x | 35.25x | 31.41x |
| Beam Therapeutics Inc. (BEAM)vs › | $2.60B | N/A | 44.45x | 44.45x | 44.45x |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.60B | N/A | N/A | N/A | N/A |
| Disc Medicine, Inc. (IRON)vs › | $2.37B | N/A | N/A | N/A | N/A |
| Neogen Corporation (NEOG)vs › | $2.61B | N/A | 247.54x | 95.89x | 78.72x |
| ADMA Biologics, Inc. (ADMA)vs › | $2.36B | 20.84x | 65.64x | 95.37x | 95.37x |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.35B | N/A | 74.09x | 74.09x | 74.09x |
EV/FCF
124.9x
P/FCF
132.3x
FCF Yield
0.76%
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2026-10-05 | 124.73x |
| 2026-10-02 | 123.55x |
| 2026-10-01 | 122.94x |
| 2026-09-30 | 125.59x |
| 2026-09-29 | 128.47x |
| 2026-09-28 | 130.42x |
| 2026-09-25 | 124.42x |
| 2026-09-24 | 126.37x |
| 2026-09-23 | 126.68x |
| 2026-09-22 | 127.79x |
| 2026-09-21 | 124.79x |
| 2026-09-18 | 122.38x |
| 2026-09-17 | 125.22x |
| 2026-09-16 | 120.46x |
| 2026-09-15 | 120.15x |
| 2026-09-14 | 120.80x |
| 2026-09-11 | 121.27x |
| 2026-09-10 | 121.42x |
| 2026-09-09 | 122.60x |
| 2026-09-08 | 123.71x |
| 2026-09-04 | 127.11x |
| 2026-09-03 | 128.47x |
| 2026-09-02 | 128.65x |
| 2026-09-01 | 127.76x |
| 2026-08-31 | 129.21x |
| 2026-08-28 | 127.73x |
| 2026-08-27 | 129.15x |
| 2026-08-26 | 131.28x |
| 2026-08-25 | 132.77x |
| 2026-08-24 | 131.99x |
| 2026-08-21 | 134.28x |
| 2026-08-20 | 139.23x |
| 2026-08-19 | 142.60x |
| 2026-08-18 | 144.11x |
| 2026-08-17 | 141.76x |
| 2026-08-14 | 141.76x |
| 2026-08-13 | 138.30x |
| 2026-08-12 | 140.52x |
| 2026-08-11 | 137.46x |
| 2026-08-10 | 138.05x |
| 2026-08-07 | 139.81x |
| 2026-08-06 | 137.09x |
| 2026-08-05 | 137.56x |
| 2026-08-04 | 126.24x |
| 2026-08-03 | 30.49x |
| 2026-07-31 | 29.53x |
| 2026-07-30 | 30.22x |
| 2026-07-29 | 30.89x |
| 2026-07-28 | 31.70x |
| 2026-07-27 | 31.18x |
| 2026-07-24 | 30.63x |
| 2026-07-23 | 31.33x |
| 2026-07-22 | 31.15x |
| 2026-07-21 | 31.80x |
| 2026-07-20 | 31.49x |
| 2026-07-17 | 31.92x |
| 2026-07-16 | 32.04x |
| 2026-07-15 | 31.70x |
| 2026-07-14 | 30.95x |
| 2026-07-13 | 31.44x |
| 2026-07-10 | 32.22x |
| 2026-07-09 | 32.42x |
| 2026-07-08 | 33.60x |
| 2026-07-07 | 31.85x |
| 2026-07-06 | 31.36x |
| 2026-07-02 | 31.93x |
| 2026-07-01 | 31.48x |
| 2026-06-30 | 30.85x |
| 2026-06-29 | 31.05x |
| 2026-06-26 | 31.08x |
| 2026-06-25 | 29.62x |
| 2026-06-24 | 29.89x |
| 2026-06-23 | 29.43x |
| 2026-06-22 | 29.43x |
| 2026-06-18 | 29.36x |
| 2026-06-17 | 28.80x |
| 2026-06-16 | 28.80x |
| 2026-06-15 | 28.99x |
| 2026-06-12 | 29.38x |
| 2026-06-11 | 30.18x |
| 2026-06-10 | 29.85x |
| 2026-06-09 | 30.25x |
| 2026-06-08 | 29.43x |
| 2026-06-05 | 29.62x |
| 2026-06-04 | 29.58x |
| 2026-06-03 | 29.12x |
| 2026-06-02 | 29.14x |
| 2026-06-01 | 29.62x |
| 2026-05-29 | 30.62x |
| 2026-05-28 | 31.09x |
| 2026-05-27 | 30.94x |
| 2026-05-26 | 31.73x |
| 2026-05-22 | 32.04x |
| 2026-05-21 | 32.86x |
| 2026-05-20 | 32.38x |
| 2026-05-19 | 31.63x |
| 2026-05-18 | 32.13x |
| 2026-05-15 | 32.90x |
| 2026-05-14 | 34.14x |
| 2026-05-13 | 34.25x |
| 2026-05-12 | 33.67x |
| 2026-05-11 | 32.85x |
| 2026-05-08 | 34.37x |
| 2026-05-07 | 34.89x |
| 2026-05-06 | 34.31x |
| 2026-05-05 | 59.43x |
| 2026-05-04 | 58.73x |
| 2026-05-01 | 57.76x |
| 2026-04-30 | 57.94x |
| 2026-04-29 | 58.63x |
| 2026-04-28 | 58.80x |
| 2026-04-27 | 59.76x |
| 2026-04-24 | 60.14x |
| 2026-04-23 | 60.92x |
| 2026-04-22 | 60.80x |
| 2026-04-21 | 59.34x |
| 2026-04-20 | 62.00x |
| 2026-04-17 | 62.17x |
| 2026-04-16 | 59.47x |
| 2026-04-15 | 60.36x |
| 2026-04-14 | 60.58x |
| 2026-04-13 | 60.38x |
| 2026-04-10 | 61.29x |
| 2026-04-09 | 62.31x |
| 2026-04-08 | 62.45x |
| 2026-04-07 | 61.64x |
| 2026-04-06 | 61.11x |
| 2026-04-02 | 61.04x |
| 2026-04-01 | 62.23x |
| 2026-03-31 | 62.55x |
| 2026-03-30 | 59.63x |
| 2026-03-27 | 59.84x |
| 2026-03-26 | 61.44x |
| 2026-03-25 | 60.51x |
| 2026-03-24 | 59.67x |
| 2026-03-23 | 59.50x |
| 2026-03-20 | 57.65x |
| 2026-03-19 | 58.99x |
| 2026-03-18 | 59.55x |
| 2026-03-17 | 61.46x |
| 2026-03-16 | 60.70x |
| 2026-03-13 | 60.33x |
| 2026-03-12 | 61.01x |
| 2026-03-11 | 64.45x |
| 2026-03-10 | 65.01x |
| 2026-03-09 | 65.64x |
| 2026-03-06 | 65.26x |
| 2026-03-05 | 65.76x |
| 2026-03-04 | 67.40x |
| 2026-03-03 | 66.12x |
| 2026-03-02 | 42.49x |
| 2026-02-27 | 42.20x |
| 2026-02-26 | 43.02x |
| 2026-02-25 | 43.47x |
| 2026-02-24 | 41.06x |
| 2026-02-23 | 38.97x |
| 2026-02-20 | 39.11x |
| 2026-02-19 | 39.50x |
| 2026-02-18 | 38.58x |
| 2026-02-17 | 39.72x |
| 2026-02-13 | 39.09x |
| 2026-02-12 | 38.30x |
| 2026-02-11 | 39.49x |
| 2026-02-10 | 39.37x |
| 2026-02-09 | 39.46x |
| 2026-02-06 | 39.74x |
| 2026-02-05 | 37.92x |
| 2026-02-04 | 37.69x |
| 2026-02-03 | 37.14x |
| 2026-02-02 | 37.45x |
| 2026-01-30 | 36.95x |
| 2026-01-29 | 37.67x |
| 2026-01-28 | 37.58x |
| 2026-01-27 | 37.98x |
| 2026-01-26 | 37.75x |
| 2026-01-23 | 37.02x |
| 2026-01-22 | 37.70x |
| 2026-01-21 | 38.04x |
| 2026-01-20 | 38.28x |
| 2026-01-16 | 38.42x |
| 2026-01-15 | 38.63x |
| 2026-01-14 | 39.86x |
| 2026-01-13 | 39.58x |
| 2026-01-12 | 39.51x |
| 2026-01-09 | 39.31x |
| 2026-01-08 | 39.36x |
| 2026-01-07 | 39.41x |
| 2026-01-06 | 37.83x |
| 2026-01-05 | 37.94x |
| 2026-01-02 | 38.00x |
| 2025-12-31 | 38.18x |
| 2025-12-30 | 38.33x |
| 2025-12-29 | 39.42x |
| 2025-12-26 | 39.68x |
| 2025-12-24 | 39.84x |
| 2025-12-23 | 39.79x |
| 2025-12-22 | 39.62x |
| 2025-12-19 | 39.61x |
| 2025-12-18 | 37.85x |
| 2025-12-17 | 37.42x |
| 2025-12-16 | 37.08x |
| 2025-12-15 | 36.25x |
| 2025-12-12 | 36.15x |
| 2025-12-11 | 35.63x |
| 2025-12-10 | 35.35x |
| 2025-12-09 | 34.76x |
| 2025-12-08 | 36.15x |
| 2025-12-05 | 34.97x |
| 2025-12-04 | 34.51x |
| 2025-12-03 | 34.23x |
| 2025-12-02 | 33.72x |
| 2025-12-01 | 34.19x |
| 2025-11-28 | 34.90x |
| 2025-11-26 | 35.43x |
| 2025-11-25 | 35.29x |
| 2025-11-24 | 34.55x |
| 2025-11-21 | 34.68x |
| 2025-11-20 | 34.26x |
| 2025-11-19 | 34.99x |
| 2025-11-18 | 34.35x |
| 2025-11-17 | 34.50x |
| 2025-11-14 | 34.43x |
| 2025-11-13 | 33.98x |
| 2025-11-12 | 34.12x |
| 2025-11-11 | 35.31x |
| 2025-11-10 | 34.75x |
| 2025-11-07 | 35.24x |
| 2025-11-06 | 13.80x |
| 2025-11-05 | 13.75x |
| 2025-11-04 | 16.76x |
| 2025-11-03 | 16.37x |
| 2025-10-31 | 16.19x |
| 2025-10-30 | 16.61x |
| 2025-10-29 | 16.36x |
| 2025-10-28 | 15.60x |
| 2025-10-27 | 15.46x |
| 2025-10-24 | 15.49x |
| 2025-10-23 | 15.25x |
| 2025-10-22 | 14.83x |
| 2025-10-21 | 14.83x |
| 2025-10-20 | 15.11x |
| 2025-10-17 | 14.68x |
| 2025-10-16 | 14.56x |
| 2025-10-15 | 14.41x |
| 2025-10-14 | 14.39x |
| 2025-10-13 | 14.14x |
| 2025-10-10 | 14.33x |
| 2025-10-09 | 14.48x |
| 2025-10-08 | 14.02x |
| 2025-10-07 | 14.04x |
| 2025-10-06 | 14.12x |
| 2025-10-03 | 14.13x |
| 2025-10-02 | 14.01x |
| 2025-10-01 | 14.03x |
| 2025-09-30 | 13.96x |
| 2025-09-29 | 13.90x |
| 2025-09-26 | 13.72x |
| 2025-09-25 | 13.77x |
| 2025-09-24 | 13.75x |
| 2025-09-23 | 13.66x |
Showing the most recent 260 of 2,908 data points. The chart above shows the full history.
